UCN-01 alters phosphorylation of Akt and GSK3β and induces apoptosis in six independent human neuroblastoma cell lines

Sai Latha Shankar, Melissa Krupski, Bhupesh Parashar, Chidi Okwuaka, Kathy O'Guin, Sridhar Mani, Bridget Shafit-Zagardo

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

In this study we evaluated UCN-01, a small molecule that inhibits protein kinases by interacting with the ATP-binding site, as a potential anti-cancer agent for neuroblastoma. UCN-01 was effective at inducing apoptosis in six neuroblastoma cell lines with diverse cellular and genetic phenotypes. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling (TUNEL) assays, detection of active caspase-3 and cleaved poly ADP-ribose polymerase (PARP) confirmed that UCN-01 induced apoptosis. Cell cycle analysis determined that the UCN-01 treated cells accumulated in S phase by 16 h. Unlike vinblastine and docetaxel that increased survivin expression, UCN-01 treatment did not increase X-linked inhibitor of apoptosis protein (XIAP) and survivin levels. Analysis of specific phosphoepitopes on chk1/2, Akt, and GSK3β following UCN-01 treatment determined that there was no significant change in phospho-chk1/2. However, there was decreased immunoreactivity at Ser473 and Thr308 of Akt and Ser9 of GSK3β by 4 h indicating that the Akt survival pathway and downstream signalling was compromised. Thus, UCN-01 was effective at inducing apoptosis in neuroblastoma cell lines.

Original languageEnglish (US)
Pages (from-to)702-711
Number of pages10
JournalJournal of Neurochemistry
Volume90
Issue number3
DOIs
StatePublished - Aug 2004

Fingerprint

Phosphorylation
Neuroblastoma
Cells
Apoptosis
Cell Line
docetaxel
X-Linked Inhibitor of Apoptosis Protein
DNA Nucleotidylexotransferase
Poly(ADP-ribose) Polymerases
Vinblastine
7-hydroxystaurosporine
S Phase
Caspase 3
Protein Kinases
Labeling
Assays
Cell Cycle
Adenosine Triphosphate
Binding Sites
Phenotype

Keywords

  • 7-hydroxystaurosporine (UCN-01)
  • Akt
  • Apoptosis
  • GSK3β
  • Neuroblastomas
  • Staurosporine
  • Survivin

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

UCN-01 alters phosphorylation of Akt and GSK3β and induces apoptosis in six independent human neuroblastoma cell lines. / Shankar, Sai Latha; Krupski, Melissa; Parashar, Bhupesh; Okwuaka, Chidi; O'Guin, Kathy; Mani, Sridhar; Shafit-Zagardo, Bridget.

In: Journal of Neurochemistry, Vol. 90, No. 3, 08.2004, p. 702-711.

Research output: Contribution to journalArticle

Shankar, Sai Latha ; Krupski, Melissa ; Parashar, Bhupesh ; Okwuaka, Chidi ; O'Guin, Kathy ; Mani, Sridhar ; Shafit-Zagardo, Bridget. / UCN-01 alters phosphorylation of Akt and GSK3β and induces apoptosis in six independent human neuroblastoma cell lines. In: Journal of Neurochemistry. 2004 ; Vol. 90, No. 3. pp. 702-711.
@article{cb38dfa54b734745a7fa947e7e1078b7,
title = "UCN-01 alters phosphorylation of Akt and GSK3β and induces apoptosis in six independent human neuroblastoma cell lines",
abstract = "In this study we evaluated UCN-01, a small molecule that inhibits protein kinases by interacting with the ATP-binding site, as a potential anti-cancer agent for neuroblastoma. UCN-01 was effective at inducing apoptosis in six neuroblastoma cell lines with diverse cellular and genetic phenotypes. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling (TUNEL) assays, detection of active caspase-3 and cleaved poly ADP-ribose polymerase (PARP) confirmed that UCN-01 induced apoptosis. Cell cycle analysis determined that the UCN-01 treated cells accumulated in S phase by 16 h. Unlike vinblastine and docetaxel that increased survivin expression, UCN-01 treatment did not increase X-linked inhibitor of apoptosis protein (XIAP) and survivin levels. Analysis of specific phosphoepitopes on chk1/2, Akt, and GSK3β following UCN-01 treatment determined that there was no significant change in phospho-chk1/2. However, there was decreased immunoreactivity at Ser473 and Thr308 of Akt and Ser9 of GSK3β by 4 h indicating that the Akt survival pathway and downstream signalling was compromised. Thus, UCN-01 was effective at inducing apoptosis in neuroblastoma cell lines.",
keywords = "7-hydroxystaurosporine (UCN-01), Akt, Apoptosis, GSK3β, Neuroblastomas, Staurosporine, Survivin",
author = "Shankar, {Sai Latha} and Melissa Krupski and Bhupesh Parashar and Chidi Okwuaka and Kathy O'Guin and Sridhar Mani and Bridget Shafit-Zagardo",
year = "2004",
month = "8",
doi = "10.1111/j.1471-4159.2004.02543.x",
language = "English (US)",
volume = "90",
pages = "702--711",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - UCN-01 alters phosphorylation of Akt and GSK3β and induces apoptosis in six independent human neuroblastoma cell lines

AU - Shankar, Sai Latha

AU - Krupski, Melissa

AU - Parashar, Bhupesh

AU - Okwuaka, Chidi

AU - O'Guin, Kathy

AU - Mani, Sridhar

AU - Shafit-Zagardo, Bridget

PY - 2004/8

Y1 - 2004/8

N2 - In this study we evaluated UCN-01, a small molecule that inhibits protein kinases by interacting with the ATP-binding site, as a potential anti-cancer agent for neuroblastoma. UCN-01 was effective at inducing apoptosis in six neuroblastoma cell lines with diverse cellular and genetic phenotypes. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling (TUNEL) assays, detection of active caspase-3 and cleaved poly ADP-ribose polymerase (PARP) confirmed that UCN-01 induced apoptosis. Cell cycle analysis determined that the UCN-01 treated cells accumulated in S phase by 16 h. Unlike vinblastine and docetaxel that increased survivin expression, UCN-01 treatment did not increase X-linked inhibitor of apoptosis protein (XIAP) and survivin levels. Analysis of specific phosphoepitopes on chk1/2, Akt, and GSK3β following UCN-01 treatment determined that there was no significant change in phospho-chk1/2. However, there was decreased immunoreactivity at Ser473 and Thr308 of Akt and Ser9 of GSK3β by 4 h indicating that the Akt survival pathway and downstream signalling was compromised. Thus, UCN-01 was effective at inducing apoptosis in neuroblastoma cell lines.

AB - In this study we evaluated UCN-01, a small molecule that inhibits protein kinases by interacting with the ATP-binding site, as a potential anti-cancer agent for neuroblastoma. UCN-01 was effective at inducing apoptosis in six neuroblastoma cell lines with diverse cellular and genetic phenotypes. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling (TUNEL) assays, detection of active caspase-3 and cleaved poly ADP-ribose polymerase (PARP) confirmed that UCN-01 induced apoptosis. Cell cycle analysis determined that the UCN-01 treated cells accumulated in S phase by 16 h. Unlike vinblastine and docetaxel that increased survivin expression, UCN-01 treatment did not increase X-linked inhibitor of apoptosis protein (XIAP) and survivin levels. Analysis of specific phosphoepitopes on chk1/2, Akt, and GSK3β following UCN-01 treatment determined that there was no significant change in phospho-chk1/2. However, there was decreased immunoreactivity at Ser473 and Thr308 of Akt and Ser9 of GSK3β by 4 h indicating that the Akt survival pathway and downstream signalling was compromised. Thus, UCN-01 was effective at inducing apoptosis in neuroblastoma cell lines.

KW - 7-hydroxystaurosporine (UCN-01)

KW - Akt

KW - Apoptosis

KW - GSK3β

KW - Neuroblastomas

KW - Staurosporine

KW - Survivin

UR - http://www.scopus.com/inward/record.url?scp=3342970980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3342970980&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2004.02543.x

DO - 10.1111/j.1471-4159.2004.02543.x

M3 - Article

C2 - 15255949

AN - SCOPUS:3342970980

VL - 90

SP - 702

EP - 711

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 3

ER -